PLASMA AND HEPATIC CARNITINE AND COENZYME-A POOLS IN A PATIENT WITH FATAL, VALPROATE-INDUCED HEPATOTOXICITY

被引:39
作者
KRAHENBUHL, S [1 ]
MANG, G [1 ]
KUPFERSCHMIDT, H [1 ]
MEIER, PJ [1 ]
KRAUSE, M [1 ]
机构
[1] UNIV ZURICH HOSP, DEPT INTERNAL MED, DIV CLIN PHARMACOL & TOXICOL, CH-8091 ZURICH, SWITZERLAND
关键词
CARNITINE; COENZYME A; LIVER TOXICITY; VALPROATE;
D O I
10.1136/gut.37.1.140
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Reduced hepatic mitochondrial P-oxidation and changes in the plasma carnitine pool are important biochemical findings in valproate induced Liver toxicity. The carnitine pools in plasma and Liver and the liver coenzyme A (CoA) pool in a patient with fatal, valproate induced hepatotoxicity were measured. In plasma and liver the free and total carnitine contents were decreased, whereas the ratios short chain acylcarnitine/total acid soluble carnitine were increased. The long chain acylcarnitine content was unchanged in plasma, and increased in liver. The total CoA content in liver was decreased by 84%. This was due to reduced concentrations of CoASH, acetyl-CoA, and long chain acyl-CoA whereas the concentrations of succinyl-CoA and propionyl-CoA were both increased. The good agreement between the plasma and liver carnitine pools reflects the close relation between these two pools. The observed decrease in the hepatic CoASH and total CoA content has so far not been reported in humans with valproate induced hepatotoxicity and may be functionally significant.
引用
收藏
页码:140 / 143
页数:4
相关论文
共 45 条
[1]   INFLUENCE OF VALPROIC ACID ON HEPATIC CARBOHYDRATE AND LIPID-METABOLISM [J].
BECKER, CM ;
HARRIS, RA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 223 (02) :381-392
[2]   FATAL NEONATAL LIVER-FAILURE AND MITOCHONDRIAL CYTOPATHY (OXIDATIVE-PHOSPHORYLATION DEFICIENCY) - A LIGHT AND ELECTRON-MICROSCOPIC STUDY OF THE LIVER [J].
BIOULACSAGE, P ;
PARROTROULAUD, F ;
MAZAT, JP ;
LAMIREAU, T ;
COQUET, M ;
SANDLER, B ;
DEMARQUEZ, JL ;
CORMIER, V ;
MUNNICH, A ;
CARRE, M ;
BALABAUD, C .
HEPATOLOGY, 1993, 18 (04) :839-846
[3]  
BOHAN TP, 1992, CURRENT CONCEPTS IN CARNITINE RESEARCH, P19
[4]   DECREASED SERUM CARNITINE IN VALPROATE INDUCED REYE SYNDROME [J].
BOHLES, H ;
RICHTER, K ;
WAGNERTHIESSEN, E ;
SCHAFER, H .
EUROPEAN JOURNAL OF PEDIATRICS, 1982, 139 (03) :185-186
[5]  
BRASS EP, 1978, J BIOL CHEM, V253, P2688
[6]   METHOD FOR DETERMINATION OF CARNITINE IN PICOMOLE RANGE [J].
CEDERBLA.G ;
LINDSTED.S .
CLINICA CHIMICA ACTA, 1972, 37 (NMAR) :235-&
[7]   RADIOISOTOPIC ASSAYS OF COASH AND CARNITINE AND THEIR ACETYLATED FORMS IN HUMAN SKELETAL-MUSCLE [J].
CEDERBLAD, G ;
CARLIN, JI ;
CONSTANTINTEODOSIU, D ;
HARPER, P ;
HULTMAN, E .
ANALYTICAL BIOCHEMISTRY, 1990, 185 (02) :274-278
[8]   URINARY-EXCRETION OF L-CARNITINE AND ACYLCARNITINES BY PATIENTS WITH DISORDERS OF ORGANIC-ACID METABOLISM - EVIDENCE FOR SECONDARY INSUFFICIENCY OF L-CARNITINE [J].
CHALMERS, RA ;
ROE, CR ;
STACEY, TE ;
HOPPEL, CL .
PEDIATRIC RESEARCH, 1984, 18 (12) :1325-1328
[9]  
DESCHAMPS D, 1991, J PHARMACOL EXP THER, V259, P894
[10]   VALPROIC ACID HEPATIC FATALITIES - A RETROSPECTIVE REVIEW [J].
DREIFUSS, FE ;
SANTILLI, N ;
LANGER, DH ;
SWEENEY, KP ;
MOLINE, KA ;
MENANDER, KB .
NEUROLOGY, 1987, 37 (03) :379-385